![Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468294221001398-gr1.jpg)
Immunotherapy in colorectal cancer: is the long-awaited revolution finally happening? - ScienceDirect
![Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2022/edbk.2022.42/edbk_349811/20230421/images/large/edbk_349811-table3.jpeg)
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
View of The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation | Annals of Gastroenterology
![Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities](https://www.frontiersin.org/files/Articles/795972/fimmu-13-795972-HTML/image_m/fimmu-13-795972-g001.jpg)
Frontiers | Neoadjuvant Immunotherapy for MSI-H/dMMR Locally Advanced Colorectal Cancer: New Strategies and Unveiled Opportunities
![Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-020-0805-8/MediaObjects/41591_2020_805_Fig1_HTML.png)
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
![Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-0116-z/MediaObjects/41392_2020_116_Fig1_HTML.png)
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
![Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S237277052100067X-fx1.jpg)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
![Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/edbk/2022/edbk.2022.42/edbk_349557/20230421/images/large/edbk_349557-table3.jpeg)
Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book
![Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics](https://www.cell.com/cms/attachment/fe936ea0-58b6-483f-892a-906431186e7f/gr4_lrg.jpg)
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
![Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-019-0126-x/MediaObjects/41575_2019_126_Fig1_HTML.png)